This finding is in consonance with evidence obtained in lung carcinoma cells, where the loss of function of EZH2 leads to the acquisition of mesenchymal features and changes in tumour colonisation capacity [6–9, 17]. The gene discussed is EZH2; the disease is neoplasm.